PreCombTherapeutics AG is a privately held Swiss biotechcompany focused on in vitro cancer diagnostic to improve cancer management. It’s automated microtumor-based 3DTwin™ technology enables clinical institutions to integrate the technology on-site in the hospital. The test makes it possible to functionally evaluate multiple cancer drugs, drug combinations and drug concentrations directly on patient-derived micro-tumors to maximize treatment outcome.
Company Details
- Employees
- 14
- Founded
- -
- Address
- Garstligweg 8, Hombrechtikon,zurich 8634,switzerland
- in****@****omb.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- precomb.com
- Keywords
- Oncology, Combination therapies, Biotechnology, 3D tissue culture, Precision medicine, Drug profiling, Healthcare, Cancer therapy, Medtech, Life science, AI, Personalized oncology.
- HQ
- Hombrechtikon, Zurich
Precomb Questions
Precomb's website is precomb.com
Precomb's LinkedIn profile is https://ch.linkedin.com/company/precomb
Precomb has
14 employees.
View email and phone details for 14
employees at Precomb.
Precomb's industry is
Biotechnology Research
Precomb's top competitors are
Smartlayer.ai,
Sonect,
Teysha Technologies,
Kinled Holding Ltd,
Receptor.ai,
Gt Wings,
Deep Breath Intelligence,
Sustainable Times,
Vienga Ltd,
2curex - Individualizing Cancer Treatment.
Precomb's support email address is info@precomb.com
Precomb's categories are Biotechnology Research
Precomb's founding year is 2018
